RT Journal Article
SR Electronic
T1 Simvastatin-Induced Meralgia Paresthetica
JF The Journal of the American Board of Family
                Medicine
JO J Am Board Fam Med
FD American Board of Family Medicine
SP 469
OP 473
DO 10.3122/jabfm.2011.04.100229
VO 24
IS 4
A1 Sasson Menahem
A1 Pesach Shvartzman
YR 2011
UL http://www.jabfm.org/content/24/4/469.abstract
AB 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) cause mainly muscular adverse effects. During the last 20 years there has been solid evidence of peripheral neuropathy caused by statins, with a risk of one in 10,000 patients treated for 1 year. Meralgia paresthetica is an entrapment neuropathy occasionally encountered by primary care physicians. To date there has been no report of entrapment neuropathy that could have been caused or aggravated by statins. This case report presents meralgia paresthetica aggravated by simvastatin use that disappeared after simvastatin cessation.